Xcout IntelEndocyte
Endocyte was a biopharmaceutical company that developed targeted small-molecule drug conjugates and radioligand therapies for cancer. Its lead program, PSMA-targeted lutetium-177…
The full profile of Endocyte
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Endocyte →Already a subscriber? Sign in
Xcout Intel tracks Endocyte continuously — this profile deepens as new filings, funding, people and hiring data arrive.